Commentary/Response to Damkier et al.

Documenti analoghi

• Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations
  di: Thomas Goedecke, et al.
  Pubblicazione: (2024)
• Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation
  di: A. de Burgos‐González, et al.
  Pubblicazione: (2025)
• Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real‐world data source on medication use in pregnancy in Belgium
  di: Michael Ceulemans, et al.
  Pubblicazione: (2024)
• Comment on: “Evaluating the Accuracy of Responses by Large Language Models for Information on Disease Epidemiology”
  di: Divà Beltramin, et al.
  Pubblicazione: (2025)
• Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024
  di: Luis Fernando Valladales‐Restrepo, et al.
  Pubblicazione: (2026)